GBD 2021 Antimicrobial Resistance Collaborators. Global burden of bacterial antimicrobial resistance 1990–2021: A systematic analysis with forecasts to 2050. Lancet, 2024; 404(10459):1199–1226.
2.
CallandJK, HaukkaK, KpordzeSW, et al.Population structure and antimicrobial resistance among Klebsiella isolates sampled from human, animal, and environmental sources in Ghana: A cross-sectional genomic One Health study. Lancet Microbe, 2023; 4(11):e943–e952.
3.
GaibaniP, BiancoG, AmadesiS, et al.Increased copy number and OmpK35 and OmpK36 porins disruption mediated resistance to Imipenem/Relebactam and Meropenem/Vaborbactam in a KPC-producing Klebsiella pneumoniae clinical isolate. Antimicrob Agents Chemother, 2022; 66(5):e0019122.
4.
LamMMC, WickRR, WattsSC, et al.A genomic surveillance framework and genotyping tool for Klebsiella pneumoniae and its related species complex. Nat Commun, 2021; 12(1):4188.
5.
Batisti BiffignandiG, BellinzonaG, PetazzoniG, et al.P-DOR, an easy-to-use pipeline to reconstruct bacterial outbreaks using genomics. Bioinformatics, 2023; 39(9):btad571; doi: 10.1093/bioinformatics/btad571
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
